PharmGen Science, Inc. (KRX:004720)
South Korea · Delayed Price · Currency is KRW 4,235.00
-20.00 (-0.47%)
Last updated: Jan 29, 2026, 1:56 PM KST
PharmGen Science Market Cap
PharmGen Science has a market cap or net worth of 93.24 billion as of January 29, 2026. Its market cap has increased by 25.69% in one year.
Market Cap
93.24B
Enterprise Value
98.58B
Revenue
171.66B
Ranking
n/a
PE Ratio
791.83
Stock Price
4,235.00
Market Cap Chart
Since August 31, 1995, PharmGen Science's market cap has increased from 10.89B to 93.24B, an increase of 756.03%. That is a compound annual growth rate of 7.31%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 28, 2026 | 93.24B | 2.41% |
| Dec 30, 2025 | 91.05B | 22.74% |
| Dec 30, 2024 | 74.18B | -33.39% |
| Dec 28, 2023 | 111.36B | 5.58% |
| Dec 29, 2022 | 105.47B | -33.88% |
| Dec 30, 2021 | 159.51B | -3.78% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 82.86T |
| Celltrion | 46.28T |
| ALTEOGEN | 21.71T |
| ABL Bio | 13.42T |
| Aprogen Biologics | 102.15B |
| Enzychem Lifesciences | 102.09B |
| CG Invites | 100.65B |
| Amicogen | 97.34B |